1. Home
  2. CNXN vs ANIP Comparison

CNXN vs ANIP Comparison

Compare CNXN & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PC Connection Inc.

CNXN

PC Connection Inc.

HOLD

Current Price

$88.21

Market Cap

2.0B

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$77.29

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXN
ANIP
Founded
1982
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1997
1999

Fundamental Metrics

Financial Performance
Metric
CNXN
ANIP
Price
$88.21
$77.29
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$110.00
AVG Volume (30 Days)
98.9K
353.5K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
1.26%
N/A
EPS Growth
N/A
419.23
EPS
1.99
2.32
Revenue
N/A
$206,547,000.00
Revenue This Year
$6.24
$21.01
Revenue Next Year
$4.39
$17.59
P/E Ratio
$43.17
$33.99
Revenue Growth
N/A
2.47
52 Week Low
$54.97
$69.58
52 Week High
$88.35
$96.99

Technical Indicators

Market Signals
Indicator
CNXN
ANIP
Relative Strength Index (RSI) 63.85 58.79
Support Level $56.09 $75.94
Resistance Level $88.31 $78.20
Average True Range (ATR) 2.22 1.97
MACD 0.30 1.00
Stochastic Oscillator 79.74 80.25

Price Performance

Historical Comparison
CNXN
ANIP

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: